In the latest quarter, 12 analysts provided ratings for Procter & Gamble PG, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 7 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 2 | 3 | 5 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $173.0, a high estimate of $209.00, and a low estimate of $155.00. A decline of 1.1% from the prior average price target is evident in the current average.
Analyzing Analyst Ratings: A Detailed Breakdown
The standing of Procter & Gamble among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $165.00 | $159.00 |
| Korinne Wolfmeyer | Piper Sandler | Lowers | Neutral | $172.00 | $173.00 |
| Nik Modi | RBC Capital | Maintains | Sector Perform | $164.00 | $164.00 |
| Mark Astrachan | Stifel | Raises | Hold | $165.00 | $161.00 |
| Chris Carey | Wells Fargo | Raises | Overweight | $180.00 | $176.00 |
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $159.00 | $155.00 |
| Linda Bolton Weiser | DA Davidson | Maintains | Buy | $209.00 | $209.00 |
| Lauren Lieberman | Barclays | Lowers | Equal-Weight | $155.00 | $163.00 |
| Mark Astrachan | Stifel | Lowers | Hold | $161.00 | $167.00 |
| Peter Grom | UBS | Lowers | Buy | $189.00 | $196.00 |
| Andrea Teixeira | JP Morgan | Lowers | Overweight | $181.00 | $186.00 |
| Chris Carey | Wells Fargo | Lowers | Overweight | $176.00 | $190.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Procter & Gamble. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Procter & Gamble compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Procter & Gamble's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Procter & Gamble's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Procter & Gamble analyst ratings.
Unveiling the Story Behind Procter & Gamble
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
Procter & Gamble: A Financial Overview
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Over the 3 months period, Procter & Gamble showcased positive performance, achieving a revenue growth rate of 2.06% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Procter & Gamble's net margin excels beyond industry benchmarks, reaching 20.83%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Procter & Gamble's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 8.99%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Procter & Gamble's ROA stands out, surpassing industry averages. With an impressive ROA of 3.66%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Procter & Gamble's debt-to-equity ratio is below the industry average. With a ratio of 0.69, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: Simplified
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
